COMP

COMP

COMP Informations sur la molécule

Molecule Name
Sodium channel protein type VIII alpha subunit
Alias de la molécule
COMP,TSP5,EDM1,EPD1,MED,PSACH,THBS5
Drug Development Progress
Nombre de médicaments cliniques4
Nombre de médicaments commercialisés1
Phase de R&D la plus avancéeApproved
Alias de la cible
Sodium Channel, Voltage Gated, Type VIII Alpha Subunit,Voltage-Gated Sodium Channel Type VIII Alpha Protein,HNa6/Scn8a Voltage-Gated Sodium Channel,CERIII,EIEE13,Nav1.6,BFIS5,NaCh6,CIAT,PN4,NAV1.6 Voltage-Gated Sodium Channel,MYOCL2,Sodium channel protein type 8 subunit alpha,Sodium channel protein type VIII subunit alpha,MED,SCN8A,Sodium Voltage-Gated Channel Alpha Subunit 8,Sodium Channel, Voltage Gated, Type VIII, Alpha Subunit,Voltage-Gated Sodium Channel Subunit Alpha Nav1.6,Sodium Channel, Voltage Gated, Type VIII, Alpha Polypeptide
Contexte de la molécule
Cartilage oligomeric matrix protein (COMP) is also known as Thrombospondin-5 (TSP5), EDM1, EPD1, MED, PSACH, THBS5, which belongs to the thrombospondin family. COMP / TSP5 contains 4 EGF-like domains, 1 TSP C-terminal (TSPC) domain, 8 TSP type-3 repeats. Abundantly expressed in the chondrocyte extracellular matrix, and is also found in bone, tendon, ligament and synovium and blood vessels. COMP may play a role in the structural integrity of cartilage via its interaction with other extracellular matrix proteins such as the collagens and fibronectin. COMP can mediate the interaction of chondrocytes with the cartilage extracellular matrix through interaction with cell surface integrin receptors. Thrombospondin-5 could play a role in the pathogenesis of osteoarthritis. COMP is a marker of cartilage turnover.

COMP Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
PRAX-562PRAX-562Phase 3 ClinicalPraxis Precision Medicines
Brain Diseases; Epilepsy
Details
XEN-901NBI-921352; XEN-901Phase 2 ClinicalXenon Pharma
Epilepsies, Partial; Brain Diseases; Epilepsy
Details
PRAX-330GS-458967; GS-967; PRAX-330Phase 1 ClinicalPraxis Precision Medicines Inc
Epilepsy
Details
NBI-355NBI-355Phase 1 ClinicalNeurocrine Biosciences Inc
Epilepsy
Details

Informations sur les médicaments commercialisés

Nom anglaisCode de recherchePhase de R&DEntreprisePlus ancien nom de marquePays d'approbation le plus ancienIndication la plus ancienneSociété d'approbation la plus ancienneDate d'approbation la plus ancienneIndicationEssai clinique
Pirmenol HydrochlorideCI-845ApprovedSumitomo Dainippon, Pfizer IncPimavar, PimenolJapanArrhythmias, Cardiacnull1994-01-01
Arrhythmias, Cardiac
Details